50-950-5

CD26 Monoclonal Antibody (2A6), FITC, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-950-5-Each-of-1 In Stock ₹ 23,496.00

50-950-5 - Each of 1

₹ 23,496.00

In Stock

Quantity

1

Base Price: ₹ 23,496.00

GST (18%): ₹ 4,229.28

Total Price: ₹ 27,725.28

Antigen

CD26

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with 0.2% BSA and 0.09% sodium azide; pH 7.2

Gene Accession No.

P27487

Gene Symbols

DPP4

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

1803

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

2A6

Conjugate

FITC

Gene

DPP4

Gene Alias

ACT3; Activation molecule 3; ADABP; ADCP2; ADCP-2; ADCP-I; adenosine deaminase complexing protein; Adenosine deaminase complexing protein 2; bile canaliculus domain-specific membrane glycoprotein; CD26; Dipeptidyl peptidase 4; Dipeptidyl peptidase 4 60 kDa soluble form; Dipeptidyl peptidase 4 membrane form; Dipeptidyl peptidase 4 soluble form; Dipeptidyl peptidase IV; Dipeptidyl peptidase IV 60 kDa soluble form; Dipeptidyl peptidase IV membrane form; Dipeptidyl peptidase IV soluble form; dipeptidylpeptidase 4; dipeptidyl-peptidase 4; dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2); dipeptidylpeptidase IV (CD26, adenosine deaminase complexing protein 2); DPP IV; DPP4; Dpp-4; DPPIV; DPP-IV; GP110 glycoprotein; I79_016618; serine protease; T-cell activation antigen CD26; THAM; Thymocyte-activating molecule; TP103; WC10

Host Species

Mouse

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

50-178-01

--

Img

Invitrogen

50-178-00

--

Img

Invitrogen

56-005-942

--

Img

Invitrogen

63-005-942

--

Img

Invitrogen

62005942

--

Img

Invitrogen

63-005-182

--

Img

Invitrogen

62-005-182

--

Img

Invitrogen

67-005-182

--

Description

  • Description: The 2A6 monoclonal antibody reacts with human CD26, a 110 kDa type II transmembrane dimer
  • CD26 is an ectoenzyme with dipeptidyl peptidase IV activity expressed by T cells and is upregulated upon T cell stimulation
  • It is thought that CD26 plays a role in interaction with the extracellular matrix molecules and in T cell activation
  • Applications Reported: The 2A6 antibody has been reported for use in flow cytometric analysis
  • Applications Tested: This 2A6 antibody has been pre-titrated and tested by flow cytometric analysis of normal human peripheral blood cells
  • This can be used at 5 μL (1 μg) per test
  • A test is defined as the amount (μg) of antibody that will stain a cell sample in a final volume of 100 μL
  • Cell number should be determined empirically but can range from 10^5 to 10^8 cells/test
  • Excitation: 488 nm; Emission: 520 nm; Laser: Blue Laser
  • Filtration: 0.2 μm post-manufacturing filtered
  • CD26 (dipeptidyl peptidase IV, DPP IV), adenosine deaminase (ADA) binding protein) is a homodimeric atypical serine protease belonging to the prolyl oligopeptidase family
  • CD26 is expressed on lymphocyte cells and is upregulated during T-cell activation
  • CD26 is also expressed on activated B cells and natural killer cells and abundantly on epithelia
  • CD26 is implicated in a variety of biological functions including T-cell activation, cell adhesion with extracellular matrix such as fibronectin or collagens, and in HIV infection
  • CD26 identical to adenosine deaminase complexing protein-2, and to the T-cell activation antigen CD26
  • Further, CD26 is an intrinsic membrane glycoprotein and a serine exopeptidase that cleaves X-proline dipeptides from the N-terminus of polypeptides
  • Alterations in CD26 peptidase activity are characteristic of malignant transformation, and the enzymatic activity increases dramatically with tumor grade and severity
  • CD26 is expressed in various blood cell types, but also in cells that are histogenetically related to activated fibroblasts
  • Alterations in CD26 density have been reported on circulating monocytes and CD4+ T cells during rheumatoid arthritis and systemic lupus erythematosus.